Universal Health Coverage: A Rising Tide Floats All Boats Mark is Chairman and Partner of the Global Health Practice at KPMG. Since 2009, he has worked in over 60 countries, helping governments, public and private sector organizations with operations, strategy and policy. He has a pioneering...
Recently appointed the CEO of IPASA, the Innovative Pharmaceutical Association of South Africa; Konji has over 25 years’ experience in the Public and Private sector. She is a Medical Practitioner by training, with a Bachelor of Science degree from the University of the North (now...
Official MC for the IPASA Innovative Medicines Summit 2016 McLean Sibanda is an engineer and patent attorney. He has recently been appointed for a second term as the Chief Executive Officer of The Innovation Hub, a leading African Science Park. He has extensive experience in intellectual...
The Value of Innovation in Healthcare – Healthcare Successes Richard Bergstrom is a pharmacist by training. He received his MScPharm degree from the University of Uppsala, Sweden in 1988. Until 1992 he worked at the Medical Products Agency as Assistant Head of Registration. He moved to...
Speech by Minister of Science and Technology Naledi Pandor Naledi Pandor is South Africa’s Minister of Science and Technology. A life of exile from 1961 until 1984 resulted in an international flavour to her education. She holds a BA from the University of Botswana and Swaziland...
Summit Title slides...
Innovative Reimbursement Dr Jonathan Broomberg is Chief Executive Officer of Discovery Health, South Africa's largest health insurer, which manages 19 health funds, comprising over 3.3 million members. Jonathan studied medicine at the University of the Witwatersrand, South Africa, and then read PPE at Balliol College as a...
Medicine Patent Pool – a model for increasing access and innovation of medicines in developing countries Greg Perry joined the Medicines Patent Pool (MPP) as Executive Director in January 2013, bringing more than 20 years of experience in pharmaceuticals, intellectual property and healthcare policy to the...
Medicines Discovery & Development – a moral & economic development imperative in Africa: if not now, then when? Patrice Matchaba is the Global Head of Development, Cardio Metabolic Franchise at Novartis Pharmaceuticals. Appointed in May 2014 to this role, Patrice leads the global clinical development of the cardio...
The Global Trend Towards Personalized Medicine Michael serves as Research Director for the IMS Institute. He writes and speaks regularly on key health care topics related to the current and future place of biopharmaceuticals in healthcare. He brings a deep understanding of complex data sources and...
Opening Remarks Dr Timmy Kedijang is the current President of IPASA since 2014. Dr Kedijang is a Medical Doctor by qualification, having graduated with a Bachelors of Medicine and Surgery (MBchB) from University of KwaZulu Natal. Additionally he holds a Master’s of Science in Clinical Pharmacology...
IPASA Slide Deck Presentation...
Investment in Health Innovation Capacity: The Pre-requisite for South African-led Innovative Pharmaceuticals& Economic Activity Kelly Chibale is a full Professor of Organic Chemistry at the University of Cape Town (UCT) in South Africa. He is also a Full Member of the UCT Institute of Infectious Disease...